| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 03/23/2005 | EP1515959A1 Pharmaceutical salts of reboxetine |
| 03/23/2005 | EP1515955A2 Chemical process |
| 03/23/2005 | EP1515742A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 03/23/2005 | EP1515735A1 Botulinum toxins for treating priapism |
| 03/23/2005 | EP1515725A2 Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions |
| 03/23/2005 | EP1515719A2 Enhancing treatment of mdr cancer with adenosine a3 antagonists |
| 03/23/2005 | EP1515716A2 Indole derivatives having anti-angiogenetic activity |
| 03/23/2005 | EP1515708A1 Combinations of pde-v inhibitors and nk1 antagonists for the treatment of depression |
| 03/23/2005 | EP1401871B1 Immunological binding molecules inhibiting the syncytial fusion of trophoblast cells |
| 03/23/2005 | EP1105120B1 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION |
| 03/23/2005 | EP1032398B1 Treating postmenopausal women using ultra-low doses of estrogen |
| 03/23/2005 | EP1027064B1 A process for the removal of undersired toxic alkaloids from plants or from vegetable preparations |
| 03/23/2005 | CN1599745A Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist |
| 03/23/2005 | CN1599740A Amide substituted imidazopyridines |
| 03/23/2005 | CN1599739A Sulfonamido substituted imidazopyridines |
| 03/23/2005 | CN1599738A Urea substituted imidazopyridines |
| 03/23/2005 | CN1599737A Ring fused pyrazole derivatives |
| 03/23/2005 | CN1599730A Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof |
| 03/23/2005 | CN1599724A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity |
| 03/23/2005 | CN1599720A Tetrahydrocarbazol derivatives as ligands for g-protein-coupled receptors (gpcr) |
| 03/23/2005 | CN1599620A Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and prod |
| 03/23/2005 | CN1599614A Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
| 03/23/2005 | CN1599606A Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins |
| 03/23/2005 | CN1597689A Ledebouriella root glycoside and its preparation and application |
| 03/23/2005 | CN1597677A Compounds and methods for modulation of estrogen receptors |
| 03/23/2005 | CN1597008A Local preparation containing poloxamer and other microbe killing agent and applicator |
| 03/23/2005 | CN1596983A Composition of nanometer SOD and ginseng or its extract and its preparation method |
| 03/23/2005 | CN1596977A Anti gonadoliberin resisting hormone nucleic acid vaccine and its preparation method |
| 03/23/2005 | CN1596972A Slow-releasing oxytocic for artificial inducting maturation and ovulation and ejaculation rockfish and use |
| 03/23/2005 | CN1596970A Traditional Chinese medicament for treating woman subhealthy faligue syndrome and its preparation method |
| 03/23/2005 | CN1596961A Chinese patent drug dispersing tablet for treating gynecologic inflammation and its preparation method |
| 03/23/2005 | CN1596951A Phellodendron bark disperse tablet and its preparation method |
| 03/23/2005 | CN1596948A Antibicrobial and bacteria inhibiting external use medicine for gynecopathy |
| 03/23/2005 | CN1596943A Leech capsule |
| 03/23/2005 | CN1596941A Chinese five-kind compound medicine for treating premenstrual symptomgroup and its preparation method |
| 03/23/2005 | CN1596921A Traditional Chinese medicine for treating mastauxy and its making method |
| 03/23/2005 | CN1596916A Rat chemosterilant |
| 03/23/2005 | CN1596901A Ledebouriella root extract preparation used for treating climacteric syndrome and preparation method |
| 03/23/2005 | CN1193788C Beta 2-adrenergic receptor agonist |
| 03/23/2005 | CN1193784C Chinese medicine for treating atrophiedle uterus |
| 03/23/2005 | CN1193779C Traditional chinese medicine suppository for treating vaginitis and its preparing method |
| 03/23/2005 | CN1193771C Exterior-applied Chinese medicine for preventing and rteating ejaculation praecox and its preparing process |
| 03/23/2005 | CN1193762C Efficient biological lubricant and preparation method chereof |
| 03/23/2005 | CN1193750C Medicine for treating menopausal syndrome |
| 03/23/2005 | CN1193746C Substituted nitrobenzene derimative for medicine and other use |
| 03/22/2005 | US6869975 Linked biaryl compounds |
| 03/22/2005 | US6869962 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 03/22/2005 | US6869960 Substituted with a quinolin-3-ylmethyl- group, e.g., 2,3-dihydro-1'-((2-oxo-1,2,3,4-tetrahydro-3-quinolinyl)-methyl)spiro(1H -indene-1,4'-piperidine) |
| 03/22/2005 | US6869952 Such as 4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo(2,1-f)(1,2,4)triazin-6-ol; for treament of cancer |
| 03/22/2005 | US6869950 Such as 1-(2-chloro-4-(n-octyloxy)benzyl)-2-methyl-6-(1-pentane -sulfonylcarbamoyl)benzimidazole |
| 03/22/2005 | US6869941 Combination of drospirenone and an estrogen sulphamate for HRT |
| 03/22/2005 | US6869615 Enterically coated to prevent gastrointestinal side effects |
| 03/17/2005 | WO2005023980A2 Use of complement protein c3 and its derivatives in enhancing mammalian embryo development |
| 03/17/2005 | WO2005023812A2 Piperazines as oxytocin agonists |
| 03/17/2005 | WO2003037887A8 Therapeutic isoquinoline compounds |
| 03/17/2005 | US20050059742 Such as 5-butyl-2,4-dihydro-4-[[2'-[N-(3-chloro-2-thiophenecarbonyl)sulfamoyl]biphenyl-4-yl]methyl]-2-{2-(trifluoromethyl)phenyl]-1,2,4-triazol-3-one potassium salt, or a prostaglandin derivative, or 6-Isopropoxy-9-oxoxanthene-2-carboxylic acid (AH 6809) |
| 03/17/2005 | US20050059729 Substituted cyclic compounds |
| 03/17/2005 | US20050059700 Reacting compunds such as 6-methyl-12-oxa-tricyclo[8.2.1.0]trideca-2,4,6-trien-11-ol with compounds such as 4-(2,6-dichloro-phenyl)-piperidine to produce (+-)-cis-1-methyl-7-[[4-(2,6-dichloro-phenyl)piperidin-1-yl)]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol |
| 03/17/2005 | US20050059686 Pyrrolopyrimidines as phosphodiesterase vII inhibitors |
| 03/17/2005 | US20050059675 Antidepressants; N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-1,2-dihydro-3H-benzo[e]indole-3-carboxamide; antagonist of adrenergic receptor, serotonin receptor; anxiety, schizophrenia, Parkinson's disease, cognitive disorders, schizophrenia |
| 03/17/2005 | US20050059665 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 03/17/2005 | US20050059093 Method for detecting modulators of Notch signalling |
| 03/17/2005 | US20050059002 Novel serine protease |
| 03/17/2005 | CA2537765A1 Methods and compositions for the prevention and treatment of genitourinary disorders, including pre-term labor and leiomyomas |
| 03/17/2005 | CA2535744A1 Piperazines as oxytocin agonists |
| 03/16/2005 | EP1514874A1 Thiomorpholino steroid compounds, the use thereof for the preparation of meiosis regulating medicaments and method for the preparation thereof |
| 03/16/2005 | EP1514559A1 Arylpiperazines having activity at the serotonin 1a receptor |
| 03/16/2005 | EP1514552A1 Novel fused imidazole derivative |
| 03/16/2005 | EP1514545A1 Use of tolperisone for the treatment of spasms of organes consisting essentially of smooth muscles. |
| 03/16/2005 | EP1514544A1 Antiallergic |
| 03/16/2005 | EP1513924A1 Attenuated listeria spp. and methods for using the same |
| 03/16/2005 | EP1513865A2 Crisp polypeptides as contraceptives and inhibitors of sperm capacitation |
| 03/16/2005 | EP1513861A2 New etonogestrel esters |
| 03/16/2005 | EP1513839A1 3-substituted quinuclidines and their use |
| 03/16/2005 | EP1513831A1 Novel compounds, their use and preparation |
| 03/16/2005 | EP1513808A2 Fluorinated cyclic amides as dipeptidyl peptidase iv inhibitors |
| 03/16/2005 | EP1513588A2 Use of new etonogestrel esters |
| 03/16/2005 | EP1513587A1 Self-administered contraceptive injection of oily solution |
| 03/16/2005 | EP1513547A2 Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy |
| 03/16/2005 | EP1513536A1 Use of compounds that stimulate cgmp |
| 03/16/2005 | EP1513494A2 Film-shaped mucoadhesive administration form for administering cannabis active ingredients |
| 03/16/2005 | EP1513493A2 Analgesics |
| 03/16/2005 | EP1513419A2 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 03/16/2005 | EP1399436B1 Oxytocin agonists |
| 03/16/2005 | EP1392699B1 6h-oxazolo 4,5-e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 03/16/2005 | EP1355903B1 Pyrazole derivatives against tgf overexpression |
| 03/16/2005 | EP1351962B1 Thienopyrimidine |
| 03/16/2005 | EP1233959B1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 03/16/2005 | EP1146873B1 Anti-androgens and methods for treating disease |
| 03/16/2005 | EP1140900B1 Pyrazole compounds and uses thereof |
| 03/16/2005 | EP0837681B1 Use of 19-nor-vitamin d compounds for the prevention of hyperphosphatemia in kidney disorder patients |
| 03/16/2005 | CN1596266A Specific binding agents of human angiopoietin-2 |
| 03/16/2005 | CN1596255A Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 03/16/2005 | CN1596249A Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them |
| 03/16/2005 | CN1596127A Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 03/16/2005 | CN1596115A Treatment of hyperproliferative diseases using active vitamin D analogues |
| 03/16/2005 | CN1596107A Prevention of miscarriage with immunomodulating non-endogenous gestagen compounds |
| 03/16/2005 | CN1596105A Transdermal therapeutic systems containing steroid hormones and propylene glycol monocaprylate |
| 03/16/2005 | CN1594358A Method for reducing or inhibition of proliferation of oncogenic cells and compound used in it (variants) |
| 03/16/2005 | CN1594357A Immune regulatory gene extracting method and use in preparation of drug for treating barrenness |